Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0324897 PLATELET DECOYS AND USE THEREOF
The invention provides platelet decoys and mimics that can bind to platelet receptor substrate but do not undergo platelet activation. The invention also...
2016/0324896 LUTERIAL AND METHOD FOR ISOLATING AND CULTURING THE SAME
The present invention relates to blood-derived luterial and a method for isolating and culturing the same. The luterial according to the present invention is a...
2016/0324895 MODIFIED NATURAL KILLER CELLS, COMPOSITIONS AND USES THEREOF
Modified natural killer cells, pharmaceutical compositions comprising the modified natural killer cells and at least one pharmaceutically acceptable carrier or...
2016/0324894 GALECTIN-3 PLASMAPHERESIS THERAPY
The invention is directed to the removal of serum gal-3 from circulation by plasmapheresis, comprising at least in part donor apheresis, using gal-3 binding...
2016/0324893 CALCIUM POLYPHOSPHATE SALTS, METHODS OF MAKING AND USE IN BEVERAGE COMPOSITIONS
An equilibrium solution, such as a beverage product, containing a calcium salt of a sequestrant (such as calcium hexametaphosphate), coordinated compound of a...
2016/0324892 BACTERICIDAL COMPOSITION FOR BACTERIAL SKIN DISEASE
[Problem] To provide a bactericidal composition for bacterial skin disease against which it is difficult for bacteria that cause bacterial skin disease to...
2016/0324891 NANOCLUSTERED WATER HAVING IMPROVED MEDICAL UTILITY
The present invention relates to methods of treating or preventing an infection or infectious disease in a mammal, or sanitizing mammalian tissue, or treating...
2016/0324890 Method and Device for Preventing Microbial Resistance
A method to treat acute sinusitis as an alternative to prescribing an antibiotic or recommending over-the-counter medications by (1) providing a non-antibiotic...
2016/0324889 HIGHLY STABLE ELECTROLYTIC WATER WITH REDUCED NMR HALF LINE WIDTH
Electrolytic acid or alkaline water having a NMR half line width using 170 of from about 45 to less than 51 Hz, and an oxide reduction potential of from -1000...
2016/0324888 METHOD FOR TREATING INTERVERTEBRAL DISC DEGENERATION
An injectable carboxymethylcellulose (CMC) and methylcellulose (MC) hydrogel derived from the plant-based polysaccharide, cellulose, is provided which gels in...
2016/0324887 BINDING OF GALECTIN-3 BY LOW MOLECULAR WEIGHT PECTIN
Administration of low molecular weight (10,000-20,000 Daltons, or lower) pectins, particularly modified citrus pectins (MCP), like PectaSol-C reduces...
2016/0324886 CHITOSAN DERIVATIVES FOR INACTIVATION OF ENDOTOXINS AND SURFACE PROTECTION OF NANOPARTICLES
The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer....
2016/0324885 COMPOSITION CONTAINING MODIFIED DERIVATIVES OF A CYTIDINE ANTIMETABOLITE FOR THE TREATMENT OF SUSCEPTIBLE DISEASE
The present invention relates to homo-oligomeric derivatives of a cytidine antimetabolite and its use for the treatment of susceptible diseases. The cytidine...
2016/0324884 TREATMENT OF DIABETES WITH PENTACYCLIC TRITERPENOID SAPONIN COMPOUNDS FROM SZECHUAN MELANDIUM ROOT
The method for treating diabetes in an individual includes the step of administering a therapeutically effective amount of a pharmaceutically acceptable...
2016/0324883 CATIONIC POLYMERS AS CO-DRUGS FOR CHEMOTHERAPEUTIC AGENTS
A method for treating a biological cell is disclosed. The method administers a mixture of a chemotherapeutic drug and a co-drug that facilitates delivery of...
2016/0324882 Therapeutic Compositions Comprising Imidazole and Imidazolium Compounds
Therapeutic compositions comprising substituted imidazole or imidazolium compounds may be used for a number of medical purposes, such as treatment of...
2016/0324881 Neurokinin-1 Receptor Antagonists For Use In A Method Of Prevention Of Cancer
Subject matter of the present invention is a neurokinin-1 receptor antagonist for use in a method of prevention of cancer. Particularly, subject matter of the...
2016/0324880 4-DEDIMETHYLAMINO TETRACYCLINE COMPOUNDS
The present invention pertains, at least in part, to novel substituted 4-dedimethylamino tetracycline compounds. These tetracycline compounds can be used to...
2016/0324879 SALTS AND POLYMORPHS OF A TETRACYCLINE COMPOUND
Crystalline forms, including salts and polymorphs, of a compound useful in the treatment of tetracycline compound-responsive states are provided herein. The...
2016/0324878 PHARMACEUTICAL COMPOSITIONS AND THEIR USE FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
Described herein are combination therapies for cancer (such as lymphoid malignancies) and immune diseases (such as autoimmune diseases and inflammatory...
2016/0324877 COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3
We disclose compositions comprising Vitamin D (cholecalciferol and /or ergocalciferol) and 25-OH D3 (calcifediol), and use of those compositions to affect at...
2016/0324876 VITAMIN D AND ANTIBACTERIAL USES OF COMPOSITIONS THEREOF
Uses of a vitamin D compound in the preparation of drugs for preventing or treating cystitis, urethritis and/or urinary tract infection, as well as a...
2016/0324875 CUTANEOUS COMPOSITION COMPRISING VITAMIN D ANALOGUE AND A MIXTURE OF SOLVENT AND SURFACTANTS
A pharmaceutical composition comprising a vitamin D derivative or analogue as the active ingredient dissolved in a three-component surfactant-solvent mixture...
2016/0324874 RETINOID X RECEPTOR-GAMMA AGONISTS AND RETINOID X RECEPTOR-ALPHA ANTAGONISTS FOR TREATMENT OF CANCER
The invention is directed to the use of Retinoid X Receptor-gamma (RXR-gamma) agonists and Retinoid X Receptor-alpha (RXR-alpha) antagonists in treatment of...
2016/0324873 Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone and/or its 9,11-Dehydroderivatives
The present invention refers to a new enzymatic process for obtaining 17.alpha.-monoesters of cortexolone and/or its 9,11-dehydroderivatives starting from the...
2016/0324872 IMPREGNATED DRESSINGS FOR TREATING DERMATOLOGICAL DISORDERS
This document provides methods and materials for treating dermatologic disorders. For example, methods and materials for using dressings (e.g., wet dressings)...
2016/0324871 Hypotensive lipid-containing biodegradable intraocular implants and related methods
Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide...
2016/0324870 TREATMENT OF MIGRAINES
Provided herein are prostaglandin F2alpha analog compositions and methods for treating migraines by topical administration. The method involves administering...
2016/0324869 Methods of Cosmetically Treating Skin Conditions With A Cosmetic Personal Cleansing Composition
A method of treating a skin condition including applying a rinse-off multi-phase cleansing composition including a cleansing phase including an anionic...
2016/0324868 METHODS OF TREATING PRURITUS
A method of treating pruritus (itching) in a subject in need thereof is carried out by administering the subject an active agent in a treatment effective...
2016/0324867 METHODS OF TREATING SKIN DISORDERS
A method of treating a skin disorder (e.g., an inflammatory or neoplastic skin disorder) in a subject in need thereof is carried out by administering (e.g.,...
2016/0324866 INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS
Disclosed are inhibitors of the plasmodial surface anion channel (PSAC) inhibitors and the use thereof in treating or preventing malaria in an animal such as a...
2016/0324865 TRICYCLIC PYRAZOLE SULPHONAMIDE COMPOUNDS AND METHODS OF MAKING AND USING SAME
The invention provides tricyclic sulfonamide compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of...
2016/0324864 SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
Provided are pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R.sup.1, R.sup.2, R.sup.3,...
2016/0324863 TARGETED CANCER TREATMENT BY HSP90 INHIBITORS GANETESPIB AND NVP-AUY922
Methods of treating certain cancers with ganetespib or NVP-AUY922 are disclosed. Also provided are methods of treating cancer wherein the cancer has an FGFR3...
2016/0324862 ADRENOCEPTORS ANTAGONISTS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE CONDITIONS
The present invention teaches methods for treating a variety of neurodegenerative conditions, including Alzheimer's disease (AD) and idiopathic Parkinson's...
2016/0324861 SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
Provided herein are Pyrrolopyrimidine Compounds having the following structure: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, and L are as defined ...
2016/0324860 PRODUCTS AND PHARMACEUTICAL COMPOSITIONS
The present invention relates to a product comprising a PDE1 inhibitor and a PDE2 inhibitor, in free or salt form, pharmaceutical compositions comprising them...
2016/0324859 USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
Disclosed herein are methods for treating a cancer comprising: a. administering a Btk inhibitor to a subject sufficient to result in an increase or appearance...
2016/0324858 COMPOSITIONS AND METHODS OF TREATMENT OF CANCER
This invention generally relates to compositions and methods for cancer treatment and, in particular, to compositions able to interact (e.g., bind to) with...
2016/0324857 METHOD FOR TREATING SHINGLES WITH N-METHANOCARBATHYMIDINE (N-MCT)
The present application discloses a method of treating a Varicella-Zoster Virus (VZV) infection in an individual in need thereof, including the step of...
2016/0324856 USE OF SGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
The present disclosure relates to methods, uses, pharmaceutical compositions and kits comprising a sGC stimulator or a pharmaceutically acceptable salt...
2016/0324855 COMBINATION OF A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH GEFITINIB
A pharmaceutical composition of 3-(1-{3-[5-(1-Methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo- -1,6-dihydro-pyridazin-3-yl)-benzonitrile or a...
2016/0324854 PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291
The present invention relates to pharmaceutical compositions suitable for oral administration, and more particularly to pharmaceutical compositions, including...
2016/0324853 TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM
A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic...
2016/0324852 COMPOSITIONS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE
The present application relates to new uses of 5-HT.sub.6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline or pharmaceutically...
2016/0324851 METHODS OF TREATING A NEURODEGENERATIVE DISEASE
The present application relates to new uses of 5-HT.sub.6 receptor antagonists, specifically high doses of 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline, and to...
2016/0324850 Methods and Compositions for Treating Degenerative and Ischemic Disorders
Model systems have shown that shifting a cell's reliance from oxidative phosphorylation (OXPHOS) to glycolysis can protect against cell death. Exploiting the...
2016/0324849 ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE
The present invention provides abuse deterrent mucoadhesive devices for delivery of buprenorphine. Each device comprises a mucoadhesive layer and a backing...
2016/0324848 Parenteral Formulations Of Dopamine Agonists
This invention relates to stable pharmaceutical compositions for parenteral administration comprising dopamine agonists and peripheral acting agents useful for...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.